Fatima MT, Ahmed I, Fakhro KA, Akil ASA. Melanocortin-4 receptor complexity in energy homeostasis,obesity and drug development strategies. Diab Obes Metab. 2022;24:583–98.

Article  CAS  Google Scholar 

Michael JK, Bradford BL, Alastair SG. Melanocortin-4 receptor–regulated energy homeostasis. Nat Neurosci. 2016;19:206–19.

Article  Google Scholar 

Yeo GSH, Chao DHM, Siegert AM, Koerperich ZM, Ericson MD, Simonds SE, et al. The melanocortin pathway and energy homeostasis: from discovery to obesity therapy. Mol Metab. 2021;48:101206.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu X-Y, Gregory SB, Huda A, Stanley JW. Interaction between α-melanocyte-stimulating hormone and corticotropin-releasing hormone in the regulation of feeding and hypothalamo-pituitary-adrenal responses. J Neurosci. 2003;23:7863–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krude H, Biebermann H, Luck W, Horn R, Brabant G, Grüters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet. 1998;19:155–7.

Article  CAS  PubMed  Google Scholar 

Farooqi IS, Stenvert D, Agnes C, Julia MK, Joanna B, Sarah L, et al. Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes. 2006;55:2549–53.

Article  CAS  PubMed  Google Scholar 

Schrander-Stumpel CT, Curfs LM, Sastrowijoto P, Cassidy SB, Schrander JJ, Fryns JP. Prader-Willi syndrome: causes of death in an international series of 27 cases. Am J Med Genet A. 2004;124A:333–8.

Article  PubMed  Google Scholar 

Stewart LE, Sophie JK, Arabella S, Elizabeth JE, Bruce JT, John T. Mortality in Prader-Willi syndrome. Am J Ment Retard. 2006;111:193–8.

Article  Google Scholar 

Yang-Wen H, Yi-Wen T, Hsin-Hung L, Chi-Yu L, Chiu-Ya L, Guor MH. Depletion of alpha-melanocyte-stimulating hormone induces insatiable appetite and gains in energy reserves and body weight in zebrafish. Biomedicines. 2021;9:941.

Article  Google Scholar 

Anthony M. Setmelanotide: first approval. Drugs. 2021;81:397–403.

Article  Google Scholar 

Meier JJ, Gallwitz B, Schmidt WE, Nauck MA. Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives. Eur J Pharmacol. 2002;440:269–79.

Article  CAS  PubMed  Google Scholar 

Matthew RH. Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects. Physiol Behav. 2012;106:413–6.

Article  Google Scholar 

Diene G, Angulo M, Hale PM, Jepsen CH, Hofman PL, Hokken-Koelega A, et al. Liraglutide for weight management in children and adolescents with Prader-Willi syndrome and obesity. J Clin Endocrinol Metab. 2022;108:4–12.

Article  PubMed  PubMed Central  Google Scholar 

Danilo F, Graziano G, Claudia B, Sarah B, Marco C, Antonino C. Use of GLP-1 receptor agonists in Prader-Willi syndrome: report of six cases. Diab Care. 2014;37:e76–e77.

Article  Google Scholar 

Sana A, Arooj N, Mahnoor K. Weight loss of over 100 lbs in a patient of Prader-Willi syndrome treated with glucagon-like peptide-1 (GLP-1) agonists. Cureus. 2023;15:e35102.

Google Scholar 

Ranim M, Virginia K, Merlin GB. Clinical trials in Prader-Willi syndrome: a review. Int J Mol Sci. 2023;24:2150.

Article  Google Scholar 

Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373:11–22.

Article  PubMed  Google Scholar 

John PHW, Rachel LB, Salvatore C, Melanie D, Luc FVG, Ildiko L. Once-eeekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989–1002.

Article  Google Scholar 

Ania MJ, Louis JA, Nadia NA, Sean W, Lisa C, Breno A, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:205–16.

Article  Google Scholar 

Ania MJ, Lee MK, Juan PF, Qiwei W, Yu D, Sirel G, et al. Triple-hormone-receptor agonist retatrutide for obesity—a phase 2 trial. N Engl J Med. 2023;389:514–26.

Article  Google Scholar 

Jonathan EC. Targeting the GIPR for obesity: to agonize or antagonize? Potential mechanisms. Mol Metab. 2021;46:101139.

Article  Google Scholar 

Miguel A, Sánchez-Garrido, Sara JB, Christoffer C, Timo DM, Richard DD, et al. GLP-1/glucagon receptor co-agonism for treatment of obesity. Diabetologia. 2017;60:1851–61.

Article  Google Scholar 

Haqq AM, Chung WK, Dollfus H, Haws RM, Martos-Moreno GÁ, Poitou C, et al. Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period. Lancet Diab Endocrinol. 2022;10:859–68.

Article  CAS  Google Scholar 

Silva AA, Kuo JJ, Tallam LS, Liu J, Hall JE. Does obesity induce resistance to the long-term cardiovascular and metabolic actions of melanocortin 3/4 receptor activation?. Hypertension. 2006;47:259–64.

Article  PubMed  Google Scholar 

Jerry RG, Jeffrey WM, Julia MK, Elana H, Julie HS, Gregory SC, et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med. 2009;360:44–52.

Article  Google Scholar 

Chen AS, Metzger JM, Trumbauer ME, Guan XM, Yu H, Frazier EG, et al. Role of the melanocortin-4 receptor in metabolic rate and food intake in mice. Transgenic Res. 2000;9:145–54.

Article  CAS  PubMed  Google Scholar 

Alastair SG, Chia L, Joseph CM, Bhavik PS, Emily W, Jennifer SS, et al. A neural basis for melanocortin-4 receptor-regulated appetite. Nat Neurosci. 2015;18:863–71.

Article  Google Scholar 

Niels V, Curtis BP, Michele MC, Hans-Rudolf B. Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons. Am J Physiol Regul Integr Comp Physiol. 2003;285:R470–R478.

Article  Google Scholar 

Xiaosong M, Jens B, Frances MA. Glucagon-like peptide 1 stimulates hypothalamic proopiomelanocortin neurons. J Neurosci. 2007;27:7125–9.

Article  Google Scholar 

Mitsuharu M, Hiroaki Y, Hitomi O, Kazunobu A, Tadahiro N, Sayuri N, et al. Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis. PLoS One. 2020;15:e0228212.

Article  Google Scholar 

Stina B, Karolina PS. GLP-1 and its analogs: does sex matter?. Endocrinology. 2025;166:bqae165.

Article  Google Scholar 

Peter S, James N, Zentner Ali, Jesse B, Nadia K. Factors associated with weight loss response to GLP-1 analogues for obesity treatment: a retrospective cohort analysis. BMJ Open. 2025;15:e089477.

Article  Google Scholar 

Marella M, Andrea C, Giuseppina TR, Laura N, Marco S, Paolo M, et al. Sex differences in the weight response to GLP-1RA in people with type 2 diabetes. A long-term longitudinal real-world study. Pharmacol Res. 2025;ume 219:107866.

Google Scholar 

Ilaria, Gloria G, Marianna C, Chiara G, Frida L, Danila C. Sex-differences in response to treatment with liraglutide 3.0 mg. J Clin Med. 2024;13:3369.

Article  Google Scholar 

Thomas R, Irene G, Tim K, Yuliang W, Michael S, David T. Sex differences in GLP-1 signaling across species. https://doi.org/10.1101/2025.03.17.643822.

Claudia DM, Morgane T. Sex-dependent divergence in the effects of GLP-1 agonist exendin-4 on alcohol reinforcement and reinstatement in C57BL/6J mice. Psychopharmacology (Berl). 2023;240:1287–98.

Article  Google Scholar 

Xueli Z, Yi Z, Shuobing C, Hua S. Anti-diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications. J Cachexia Sarcopenia Muscle. 2021;12:1368–79.

Article  Google Scholar 

Jing H, Tian G, Huinan Z, Xing W. Association of obesity profiles and metabolic health status with liver injury among US adult population in NHANES 1999-2016. Sci Rep. 2023;13:15958.

Article  Google Scholar 

Heather JL, Nadine SC, Richard DM, Wayne WC. Higher protein intake preserves lean mass and satiety with weight loss in pre-obese and obese women. Obesity (Silver Spring). 2007;15:421–9.

Article  Google Scholar 

Ian JN, Jennifer L, Andreas LB. Changes in lean body mass with glucagon-like peptide-1- based therapies and mitigation strategies. Diab Obes Metab. 2024;26:16–27.

Article  Google Scholar 

Pourhassan M, Bosy-Westphal A, Schautz B, Braun W, Glüer CC, Müller MJ. Impact of body composition during weight change on resting energy expenditure and homeostasis model assessment index in overweight nonsmoking adults. Am J Clin Nutr. 2014;99:779–91.

Article  CAS  PubMed